Allscripts Healthcare Solutions (MDRX) Earns Buy Rating from Analysts at Citigroup

Investment analysts at Citigroup began coverage on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) in a research note issued on Thursday, The Fly reports. The firm set a “buy” rating on the software maker’s stock.

Other analysts have also issued research reports about the stock. Dougherty & Co reiterated a “buy” rating and issued a $16.00 price objective (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a research note on Tuesday, October 3rd. Cantor Fitzgerald reiterated a “buy” rating and issued a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Wednesday, September 27th. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and set a $14.00 price objective on the stock in a research note on Tuesday, November 7th. SunTrust Banks reiterated a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, November 3rd. Finally, Maxim Group reiterated a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, November 3rd. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $14.94.

Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at $15.11 on Thursday. The firm has a market cap of $2,706.60, a price-to-earnings ratio of -13.03, a PEG ratio of 2.12 and a beta of 1.33. Allscripts Healthcare Solutions has a 52 week low of $10.24 and a 52 week high of $15.21. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.20.

In other Allscripts Healthcare Solutions news, EVP Brian Farley sold 5,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $14.35, for a total transaction of $71,750.00. Following the transaction, the executive vice president now directly owns 191,607 shares of the company’s stock, valued at $2,749,560.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP James Hewitt sold 36,796 shares of Allscripts Healthcare Solutions stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $14.11, for a total transaction of $519,191.56. Following the transaction, the senior vice president now directly owns 181,766 shares in the company, valued at $2,564,718.26. The disclosure for this sale can be found here. In the last quarter, insiders sold 56,796 shares of company stock worth $804,842. Company insiders own 0.75% of the company’s stock.

Hedge funds have recently modified their holdings of the business. TimesSquare Capital Management LLC increased its position in shares of Allscripts Healthcare Solutions by 1,322.5% during the second quarter. TimesSquare Capital Management LLC now owns 4,039,900 shares of the software maker’s stock valued at $51,549,000 after acquiring an additional 3,755,900 shares during the last quarter. First Trust Advisors LP increased its position in shares of Allscripts Healthcare Solutions by 111.5% during the fourth quarter. First Trust Advisors LP now owns 6,809,932 shares of the software maker’s stock valued at $104,737,000 after acquiring an additional 3,590,772 shares during the last quarter. Norges Bank acquired a new stake in shares of Allscripts Healthcare Solutions during the fourth quarter valued at about $28,999,000. Iridian Asset Management LLC CT increased its position in shares of Allscripts Healthcare Solutions by 26.5% during the fourth quarter. Iridian Asset Management LLC CT now owns 13,268,624 shares of the software maker’s stock valued at $135,473,000 after acquiring an additional 2,781,219 shares during the last quarter. Finally, Victory Capital Management Inc. acquired a new stake in shares of Allscripts Healthcare Solutions during the third quarter valued at about $35,840,000.

COPYRIGHT VIOLATION NOTICE: “Allscripts Healthcare Solutions (MDRX) Earns Buy Rating from Analysts at Citigroup” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/04/allscripts-healthcare-solutions-mdrx-earns-buy-rating-from-analysts-at-citigroup.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

The Fly

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Leave a Reply